CRISPR Therapeutics Congress Trades
NASDAQ: CRSPHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0
- Sales
- 0
- Politicians trading
- 0
- Latest trade
- Apr 4, 2025
CRISPR Therapeutics Congress trading summary
Members of Congress have disclosed 6 transactions in CRISPR Therapeutics (CRSP) stock, reported by 4 politicians. No CRSP trades were reported with a transaction date in the past 12 months. The most active traders are Rep. Thomas R. Suozzi (2), Sen. James M. Inhofe (2), Robert F. Kennedy (1).
The latest reported trade is a sale by Robert F. Kennedy dated Apr 4, 2025 and disclosed on May 17, 2025. The most common reported amount is $1,001 – $15,000; disclosures list value ranges, not exact amounts.
Summary generated from market data by MetaCap's automated system. Methodology
Politicians trading CRSP
CRSP trades by members of Congress
| Politician | Type | Amount | Traded | Filing |
|---|---|---|---|---|
| Robert F. KennedyRExecutive | Sell | $1,001 – $15,000 | Apr 4, 2025 | Filing for Robert F. Kennedy CRSP trade |
| Sell | $50,001 – $100,000 | Sep 20, 2021 | Filing for Thomas R. Suozzi CRSP trade | |
| Buy | $50,001 – $100,000 | Jun 3, 2021 | Filing for Thomas R. Suozzi CRSP trade | |
| BuyJoint | $1,001 – $15,000 | Jan 21, 2021 | Filing for Marjorie Taylor Greene CRSP trade | |
| Partial sell | $1,001 – $15,000 | Jan 5, 2021 | Filing for James M. Inhofe CRSP trade | |
| Partial sell | $50,001 – $100,000 | Dec 22, 2020 | Filing for James M. Inhofe CRSP trade |
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction.
Related
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction. Disclosures are shown as filed and are not a recommendation to buy or sell CRSP. How Congress trading data works